| Pharmaceutical active ingredients: |
| Hydralazine HydrochlorideIsosorbide Dinitrate |
| Available forms, composition and doses of BiDil: |
| Tablets; Oral; Hydralazine Hydrochloride 37.5 mg; Isosorbide Dinitrate 20 mg |
| BiDil medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA58 - Isosorbide dinitrate, combinationsC02DB02 - Hydralazine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NitroMed |
| Related documents and information about BiDil: |
| BiDil prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
SER-A-GEN | Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine | Solvay |
| Ser-Ap-Es | Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine | Novartis |
| Tensiocomplet | Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine | Reig Jofre |
| Tri-Hydroserpine | Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine | Watson Pharmaceuticals |
| Unipres | Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine | Solvay |
| Betadipresan | Hydralazine Hydrochloride; Propranolol Hydrochloride | Rottapharm |
| Corbetazine | Hydralazine Hydrochloride; Propranolol Hydrochloride | Sarabhai Piramal Pharma |
| Dralserp | Hydralazine Hydrochloride; Reserpine | Eon Labs |
| Serpasil-Apresoline | Hydralazine Hydrochloride; Reserpine | Novartis |
| Serathide | Hydralazine; Hydrochlorothiazide; Reserpine | Unidentified Pharmaceutical Company |